p53 controls CDC7 levels to reinforce G1 cell cycle arrest upon genotoxic stress

por Tudzarova, Slavica, Mulholland, Paul, Dey, Ayona, Stoeber, Kai, Okorokov, Andrei L., Williams, Gareth H.
Publicado 2016

SARS-CoV-2 testing and sequencing for international arrivals reveals significant cross border transmission of high risk variants into the United Kingdom

por Williams, Gareth H, Llewelyn, Alexander, Brandao, Ruben, Chowdhary, Kaiya, Hardisty, Keeda-Marie, Loddo, Marco
Publicado 2021

Cdc7 is a potent anti-cancer target in pancreatic cancer due to abrogation of the DNA origin activation checkpoint

por Huggett, Matthew T., Tudzarova, Slavica, Proctor, Ian, Loddo, Marco, Keane, Margaret G., Stoeber, Kai, Williams, Gareth H., Pereira, Stephen P.
Publicado 2016

Correction: Mapping the binding sites of antibodies utilized in programmed cell death ligand-1 predictive immunohistochemical assays for use with immuno-oncology therapies

por Lawson, Nicola L., Dix, Carly I., Scorer, Paul W., Stubbs, Christopher J., Wong, Edmond, Hutchinson, Liam, McCall, Eileen J., Schimpl, Marianne, DeVries, Emma, Walker, Jill, Williams, Gareth H., Hunt, James, Barker, Craig
Publicado 2019

Mapping the binding sites of antibodies utilized in programmed cell death ligand-1 predictive immunohistochemical assays for use with immuno-oncology therapies

por Lawson, Nicola L., Dix, Carly I., Scorer, Paul W., Stubbs, Christopher J., Wong, Edmond, Hutchinson, Liam, McCall, Eileen J., Schimpl, Marianne, DeVries, Emma, Walker, Jill, Williams, Gareth H., Hunt, James, Barker, Craig
Publicado 2019

Bladder Cancer Diagnosis and Identification of Clinically Significant Disease by Combined Urinary Detection of Mcm5 and Nuclear Matrix Protein 22

por Kelly, John D., Dudderidge, Tim J., Wollenschlaeger, Alex, Okoturo, Odu, Burling, Keith, Tulloch, Fiona, Halsall, Ian, Prevost, Teresa, Prevost, Andrew Toby, Vasconcelos, Joana C., Robson, Wendy, Leung, Hing Y., Vasdev, Nikhil, Pickard, Robert S., Williams, Gareth H., Stoeber, Kai
Publicado 2012

Clinical, Radiometabolic and Immunologic Effects of Olaparib in Locally Advanced Triple Negative Breast Cancer: The OLTRE Window of Opportunity Trial

por Schettini, Francesco, Corona, Silvia Paola, Giudici, Fabiola, Strina, Carla, Sirico, Marianna, Bernocchi, Ottavia, Milani, Manuela, Ziglioli, Nicoletta, Aguggini, Sergio, Azzini, Carlo, Barbieri, Giuseppina, Cervoni, Valeria, Cappelletti, Maria Rosa, Molteni, Alfredo, Lazzari, Maria Chiara, Ferrero, Giuseppina, Ungari, Marco, Marasco, Elena, Bruson, Alice, Xumerle, Luciano, Zago, Elisa, Cerra, Davide, Loddo, Marco, Williams, Gareth H., Paris, Ida, Scambia, Giovanni, Generali, Daniele
Publicado 2021